Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator

Heart Rhythm

Volumn 11, Issue 8, 2014, Pages 1352-1358

  Gold, Michael R ^a   Weiss, Raul ^b   Theuns, Dominic A M J ^c   Smith, Warren ^d   Leon, Angel ^e   Knight, Bradley P ^f   Carter, Nathan ^g   Husby, Michael ^g   Burke, Martin C ^h  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d AUCKLAND CITY HOSPITAL   (New Zealand)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g BOSTON SCIENTIFIC CORPORATION   (United States)

^h UNIVERSITY OF CHICAGO   (United States)

Author keywords

Inappropriate shock; Inappropriate therapy; Oversensing; Rhythm discrimination; Subcutaneous implantable defibrillator; Supraventricular tachyarrhythmia

Indexed keywords

ADULT; ALGORITHM; ARTICLE; ELECTROCARDIOGRAM; FAINTNESS; FEMALE; FOLLOW UP; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; SHOCK; SUPRAVENTRICULAR TACHYCARDIA; CARDIOVERSION; CLINICAL TRIAL; DEVICE FAILURE; ELECTROCARDIOGRAPHY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; STANDARDS; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

ALGORITHMS; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; EQUIPMENT FAILURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 84904992991     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2014.04.012     Document Type: Article

References (22)

1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias N Engl J Med 337 1997 1576 1583
2. S.J. Connolly, M. Gent, R.S. Roberts, P. Dorian, D. Roy, R.S. Sheldon, L.B. Mitchell, M.S. Green, G.J. Klein, and B. O'Brien Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone Circulation 101 2000 1297 1302
3. A.J. Moss, W. Zareba, W.J. Hall, H. Klein, D.J. Wilber, D.S. Cannom, J.P. Daubert, S.L. Higgins, M.W. Brown, and M.L. Andrews Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
4. G.H. Bardy, K.L. Lee, and D.B. Mark et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
5. D.S. Lee, A.D. Krahn, and J.S. Healey et al. Evaluation of early complications related to De Novo cardioverter defibrillator implantation: insights from the Ontario ICD database J Am Coll Cardiol 55 2010 774 782
6. A. Cheng, Y. Wang, J.P. Curtis, and P.D. Varosy Acute lead dislodgements and in-hospital mortality in patients enrolled in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry J Am Coll Cardiol 56 2010 1651 1656
7. J.E. Poole, M.J. Gleva, and T. Mela et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry Circulation 122 2010 1553 1561
8. T. Kleemann, T. Becker, K. Doenges, M. Vater, J. Senges, S. Schneider, W. Saggau, U. Weisse, and K. Seidl Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years Circulation 115 2007 2474 2480
9. G.H. Bardy, W.M. Smith, and M.A. Hood et al. An entirely subcutaneous implantable cardioverter-defibrillator N Engl J Med 363 2010 36 44
10. C.P. Rowley, and M.R. Gold Subcutaneous implantable cardioverter defibrillator Circ Arrhythm Electrophysiol 5 2012 587 593
11. R. Weiss, B.P. Knight, M.R. Gold, A.R. Leon, J.M. Herre, M. Hood, M. Rashtian, M. Kremers, I. Crozier, K.L. Lee, W. Smith, and M.C. Burke The safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator Circulation 128 2013 944 953
12. M.R. Gold, D.A. Theuns, B.P. Knight, J.L. Sturdivant, R. Sanghera, K.A. Ellenbogen, M.A. Wood, and M.C. Burke Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study J Cardiovasc Electrophysiol 23 2011 359 366
13. M.R. Gold, W. Hsu, A.F. Marcovecchio, M.R. Olsovsky, D.J. Lang, and S.R. Shorofsky A new defibrillator discrimination algorithm utilizing electrogram morphology analysis Pacing Clin Electrohysiol 22 1999 179 182
14. P. Dorian, F. Philippon, B. Thibault, S. Kimber, L. Sterns, M. Greene, D. Newman, R. Gelaznikas, and A. Barr ASTRID Investigators. Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator Heart Rhythm 1 2004 540 547
15. M.S. Wathen, P.J. DeGroot, M.O. Sweeney, A.J. Stark, M.F. Otterness, W.O. Adkisson, R.C. Canby, K. Khalighi, C. Machado, D.S. Rubenstein, and K.J. Volosin PainFREE Rx II Investigators. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter- defibrillators: acing fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) Trial results Circulation 110 2004 2591 2596
16. B.L. Wilkoff, B.D. Williamson, and R.S. Stern et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study J Am Coll Cardiol 52 2008 541 550
17. J.O.M. Schwab, M. Gasparini, and M. Lunati et al. Avoid delivering therapies for nonsustained fast ventricular tachyarrhythmia in patients with implantable cardioverter/defibrillator: the ADVANCE III Trial J Cardiovasc Electrophysiol 20 2009 663 666
18. A.J. Moss, C. Schuger, and C.A. Beck et al. Reduction in inappropriate therapy and mortality through ICD programming N Engl J Med 367 2012 2275 2283
19. M. Gasparini, A. Proclemer, C. Klersy, A. Kloppe, M. Lunati, J.B. Ferrer, A. Hersi, M. Gulaj, M.C. Wijfels, E. Santi, L. Manotta, and A. Arenal Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery:: the ADVANCE III randomized clinical trial JAMA 309 2013 1903 1911
20. M. Madhan, and P.A. Friedman Optimal programming of implantable cardiac-defibrillators Circulation 128 2013 659 672
21. J.W.E. Jarman, and D.W. Todd United Kingdom national experience of entirely subcutaneous implantable cardioverter defibrillator technology: important lessons to learn Europace 15 2013 1158 1165
22. P.D. Lambiase, C. Barr, and D.A.M.J. Theuns et al. Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry Eur Heart J 2014 Mar 26[Epub ahead of print]